Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre Open Label Phase II Study of Daratumumab in AL Amyloidosis Patients Not in VGPR or Better

NCT02816476 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.

NCT NCT02816476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02816476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre Open Label Phase II Study of Daratumumab in AL Amyloidosis Patients Not in VGPR or Better
Lead sponsor
University Hospital, Limoges
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2016
Completion date
October 31, 2020
Enrollment
40 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

amyloidosis